PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Lauds the Outstanding Product Quality of Guerbets Flagship X-ray Contrast Agent - The company is renowned for its high product quality, especially of Oxilan® (ioxilan) injection, its non-ionic low-viscous and low-osmolar monomer X-ray contrast agent
Frost & Sullivan Lauds the Outstanding Product Quality of Guerbets Flagship X-ray Contrast Agent

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2007/09/20 - The company is renowned for its high product quality, especially of Oxilan® (ioxilan) injection, its non-ionic low-viscous and low-osmolar monomer X-ray contrast agent.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan selected Guerbet as the recipient of the 2007 North American Frost & Sullivan Product Quality Leadership Award for the superiority of its contrast media products.

The company is renowned for its high product quality, especially of Oxilan® (ioxilan) injection, its non-ionic low-viscous and low-osmolar monomer X-ray contrast agent.

"Contrast media products in the medical imaging industry encounter several technical and regulatory hurdles, developmental costs, clinical testing, and FDA approval to reach a sellable stage and finally, gain acceptance by end users," says Frost & Sullivan Research Analyst AJ Ajibade. "Guerbet has implemented a product development strategy that emphasizes quality and customer satisfaction, with the high-quality technical characteristics of its contrast media products embodying the extent of its commitment."

Guerbet has Oxilan to thank for its sustained success. Despite the possibility of side effects in injection of X-ray contrast media, Oxilan has achieved remarkably positive usage feedback, confirming it to be a safe product.

Based on differences in structure, ionicity, osmolality and viscosity, contrast media are categorized under either monomers or dimmers, ionic or non-ionic, low osmolar contrast media (LOCM) or high osmolar contrast media (HOCM) and low viscous contrast media (LVCM) or high viscous contrast media (HVCM). As an LOCM and LVCM, Oxilan shows fewer adverse side effects and is the contrast media of choice for diagnostic and interventional radiology and cardiology applications.

Apart from its efficacy, Oxilan also ensures accurate diagnosis. Guerbet is aware of the significance of ionicity, chemical structure, osmolality, and viscosity in influencing the quality of contrast media, especially while considering the visualization, hemodynamics, thrombogenicity,

contrast-induced nephropathy, and other various clinical outcomes. It implemented this knowledge in the development of Oxilan to create a solution that offers first-rate imaging with minimal side effects.

"Oxilan’s unique molecular structure has a hydrophobic region within its hydrophilic side chain, which leads to molecular aggregation and a reduction in the number of osmotically active particles in solution," explains Ajibade. "This results in the lowest osmolality (695mOsm/kg H2O) and viscosity (16.3 mPa.s at 20°C) of all non-ionic monomer contrast media."

Guerbet continues to take advantage of its rich market experience in Europe and worldwide. It has developed a variety of X-ray and MR contrast agents to help provide quality products, which enables improved patient management through effective diagnosis.

Oxilan’s technical specifications and consequent product quality are invaluable benefits to the contrast media industry, a characteristic meticulously engineered by Guerbet.

Each year, Frost & Sullivan presents this Award to the company that has demonstrated superior quality control over their existing competitors in product manufacturing. Quality control is an essential element of customer satisfaction and it encourages repeat business, assuring long-term market survival. "Guerbet’s opportunity to improve disease management and impact patient care is through the commercialization of high quality, innovative contrast agents. Receiving this prestigious award from well recognized Frost and Sullivan validates that Guerbet is continuing to deliver this mission to physicians and patients," says Guerbet General Manager for USA subsidiary Amy Lutes.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Guerbet
Guerbet (guerbet-us.com) is the only pharmaceutical group fully dedicated to contrast media. It has the most comprehensive range of X-ray and MRI contrast media available worldwide. These products assist medical professionals (radiologists, cardiologists, oncologists, etc.) in better diagnosing and treating their patients (cardiovascular, cancer, inflammatory and degenerative diseases).
To develop new products and assure its future growth every year, Guerbet devotes significant resources to research and development with 160 R&D employees and investment representing an amount equivalent to 10% of sales.
Guerbet is solidly positioned in Europe with a market share of 25% and the rest of the world resulting in 8% of worldwide market share, and is expanding its presence in the United States and Japan.
In the US, Guerbet LLC markets OXILAN® (ioxilan) Injection, a nonionic low-osmolar and low-viscous agent for diagnostic and interventional procedures used by interventional cardiologists, radiologists and other specialists.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Lauds the Outstanding Product Quality of Guerbets Flagship X-ray Contrast Agent

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Stacie Jones 
210.247.2450 stacie.jones[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)